AldesleukinAZD6750IL-2
…index of IL-2 by maintaining the superior potency attributed to Aldesleukin treatment without compromising on the improved safety (as measu…
4articles mentioning drugs
11drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: aldesleukin ×
aldesleukin
This drug is selected. Its supporting articles are shown below.
Articles mentioning aldesleukin
4 articles · page 1 of 1nivolumabcyclophosphamidepembrolizumabfludarabinealdesleukinhematologic cancersWCG IRBmetastatic HPV-associated cancersmetastatic HPV-associated epithelial cancersepithelial cancers
…nt with anal cancer previously treated with 5 agents, including nivolumab. The duration of the complete responses is 8 months and 9 month…
ImneskibartAvelumabaldesleukinnivolumabAU-007Melanoma
…ommon Grade 1/2 events occurred in ≤20% of patients.Conclusions Imneskibart + low-dose SC aldesleukin possess a unique mechanism of action …
cyclophosphamidefludarabinehigh-dose interleukin-2AldesleukinUveal melanomaClinigen LimitedUniversity of PittsburghIovance Biotherapeuticsadoptive cell therapy
…usion. Patients received non-myeloablative lymphodepletion with cyclophosphamide and fludarabine, followed by infusion of TIL and high-dose inte…